---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-122758"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2021-10-05T23:59:59+00:00"
generated_at: "2026-06-28T23:02:45.141074+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Elanco to carve out microbiome R&D platform; appoints new innovation chief

## Summary
- Ellen de Brabander, Ph.D., named EVP of Innovation and Regulatory Affairs, effective Oct 18, 2021.
- Aaron Schacht will lead the carve-out of Elanco's microbiome R&D platform into an independent biopharma company.
- Carve-out expected by Q1 2022; Elanco may retain minority stake; J.P. Morgan advising.
- Elanco reaffirms 2025 innovation revenue target of $600–700M, supported by KindredBio acquisition and pipeline.
- Pet health portfolio increased as a percentage of pipeline; focus on high-value late-stage candidates.

## SEC filing metadata
- accession: 0001104659-21-122758
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2021-10-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465921122758/0001104659-21-122758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465921122758/tm2129160d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-122758
- JSON: https://secwatch.observer/filing/0001104659-21-122758.json
- Plain text: https://secwatch.observer/filing/0001104659-21-122758.txt

## Key facts
- Executive change
  Aaron Schacht changed role as Executive Vice President of Innovation, Regulatory, and Business Development at Elanco Animal Health Inc.
  - Action: transitioning
  - Role: Executive Vice President of Innovation, Regulatory, and Business Development
  source text: Aaron Schacht, Elanco’s Executive Vice President of Innovation, Regulatory, and Business Development, is transitioning to lead the potential carve-out of Elanco’s microbiome R&D platform
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465921122758/0001104659-21-122758-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.